Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,938.00
Bid: 1,937.00
Ask: 1,939.00
Change: 3.00 (0.16%)
Spread: 2.00 (0.103%)
Open: 1,938.00
High: 1,942.00
Low: 1,926.00
Prev. Close: 1,935.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MARKET TALK ROUNDUP: BROKERS COMMENTS

Tue, 06th Jul 2010 07:53

Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markettalk.eu@dowjones.com 0653 GMT [Dow Jones] Royal Bank of Scotland initiates coverage on Hikma Pharmaceuticals (HIK.LN), with a hold rating and 750p target price. "Our optimistic forecasts reflect Hikma's strong position in MENA [Middle East and North Africa] and its strategy of globalizing the platform, which should allow it to compete effectively in the US and Europe," it says. However, sees execution risk associated with the successful implementation of the global platform strategy, and with structuring value-accretive deals in an increasingly competitive M&A environment in the MENA region. "We believe the current valuation fairly reflects our (and consensus) sales and earnings growth estimates. We await more clarity on execution risks before re-considering our stance," it adds. Shares closed at 688p. (ishaq.siddiqi@dowjones.com) 0653 GMT [Dow Jones] Punch Taverns's (PUB.LN) trading update is in line with expectations, says KBC Peel Hunt. However, in view of the challenging trading outlook for FY '11, the brokerage downgrades its FY '11E pretax profit forecast by 7% to GBP123M. Says this assumes no LFL growth or margin improvement. Notes net debt has been reduced by GBP0.2B since the beginning of the year to GBP3.2B. Keeps the stock at hold and puts 90p price target under review. Shares closed Monday at 65p. (michele.maatouk@dowjones.com) 0652 GMT [Dow Jones] Goldman Sachs downgrades Majestic Wine (MJW.LN) to neutral from buy following the stock's recent outperformance. Notes that since being added to the buy list on April 22, the stock is up 9.2% vs the FTSE World Europe. Still, "we continue to view Majestic's superior sales performance, solid margins and strong returns as worthy of a multiple more in line with the EU Retail sector's historical EV/Ebitda median of 8.9x than with its own historical median of 7.7x." Keeps price target at 370p. Shares closed Monday at 308p. (michele.maatouk@dowjones.com) 0649 GMT [Dow Jones] Royal Bank of Scotland upgrades BP (BP.LN) to buy from hold, but cuts its price target at 455p from 595p. Says a decline in BP's value of $60B relative to closest peers since the Macondo oil spill blowout has created a favorable risk/reward balance. Expects the first relief well to intersect the Macondo bore by mid-July, which will be a turning point for BP's share price. "Stopping the flow of oil will cap the physical volume of the spill, reduce the daily costs being incurred, cool the political temperature and, if BP's share price remains excessively depressed, it could trigger credible merger speculation," adds RBS. Shares closed at 333p. (ishaq.siddiqi@dowjones.com) 0634 GMT [Dow Jones] Tullow Oil (TLW.LN) appears to be on track to close its Uganda asset deal with Heritage Oil (HOIL.LN), Total (TOT) and Cnooc (CEO), says Panmure Gordon analyst Peter Hitchens. "It appears Tullow has everything all sorted out apart from getting it all signed," he said, adding that full closure of the deal may take a few more weeks. Tullow will probably have little news to drive shares over the summer, but in September will drill new wells that are potentially very exciting, he adds. Gives 1500p target, buy rating. Shares closed down 0.5% Monday at 1041p. (james.herron@dowjones.com) 0628 GMT [Dow Jones] PartyGaming's (PRTY.LN) trading update for the second quarter is better than expected, Numis Securities analyst Wyn Ellis says. Adds the group's statement that it is committed to play an active role in sector consolidation will go down well with investors. Has a buy rating and 400p target price. Shares closed Monday at 221p. (simon.zekaria@dowjones.com) 0627 GMT [Dow Jones] UBS upgrades Debenhams (DEB.LN) to buy from neutral, but nudges down its price target to 75p from 77p. Says the company looks cheap on all metrics following a 20% underperformance of the UK retail sector in the last three months. Expects the management to increase focus on delivering market share gains and positive like-for-like sales growth. "The upcoming refinancing and expected reinstatement of a dividend in FY '11 should convince investors of the longer-term investment case." Shares closed Monday at 57p. (michele.maatouk@dowjones.com) 0626 GMT [Dow Jones] Persimmon (PSN.LN) reports very positive numbers ahead of the first half so shares are likely to rise after the statement, says Liberum Capital analyst. Says the company already sold GBP1.5 billion worth of homes for the year, which is really good news and that margins are also ahead of expectations. Adds that borrowings are also lower than expected. Has hold rating. Shares closed Monday at 348p. (anita.likus@dowjones.com) 0625 GMT [Dow Jones] UBS upgrades GKN (GKN.LN) to buy from neutral. Says the recent decline in its share price offers a good opportunity to buy the stock again. "Although our investment case and profit forecasts are unchanged, we believe the lower valuation now offers an attractive risk-reward profile for investors," it says. Says GKN is a well-run business with leading technologies, strong market positions and several opportunities. "In addition, we see some further upside risk to profits. Our only major concern remains a low cash conversion, largely as a result of pension payments," adds UBS. Maintains 140p target price. Shares closed at 112p. (ishaq.siddiqi@dowjones.com) 0623 GMT [Dow Jones] Investec Securities upgrades AB Foods (ABF.LN) to buy from hold and raises target to 1080p from 1060p as it takes a more positive view of Primark's valuation ahead of the company's 3Q results on July 8. Increasingly sees Primark as a winning proposition and thinks profit growth at a rate of 12% to 14% per annum is sustainable on a five-year view. Says this merits a premium rating. Thinks the market's valuation on Primark of 7-8x Ebitda/15-16x PER is too low, and reckons 8-9x ebitda is more appropriate. Shares closed Monday at 947p. (michele.maatouk@dowjones.com) Contact us in London. +44-20-7842-9288 Markettalk.eu@dowjones.com (END) Dow Jones Newswires July 06, 2010 02:53 ET (06:53 GMT)
More News
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more
3 Nov 2022 09:18

LONDON MARKET OPEN: BT results disappoint; pound falls on Fed outlook

(Alliance News) - Stock prices in London opened lower on Thursday, as the pound fell against a strengthening dollar, after the Federal Reserve indicated that US interest rates are likely to reach higher levels than previously thought.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.